These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 33839714)

  • 1. Epidemiologic Characteristics of COVID-19 in Guizhou Province, China.
    Ping K; Lei M; Gou Y; Tao Z; Yao G; Hu C; Tao Q; Zou Z; Wang D; Li S; Huang Y
    J Infect Dev Ctries; 2021 Mar; 15(3):389-397. PubMed ID: 33839714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiological characteristics of asymptomatic infection cases of COVID-19 in Guangdong province].
    Xie SL; Huang JH; Liu J; Liu J; Long QS; Xie X; Liao YH; Tang LL; Liang WJ; Zhong HJ; Li Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Sep; 41(9):1406-1410. PubMed ID: 33076590
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiological Characteristics and Incubation Period of 7015 Confirmed Cases With Coronavirus Disease 2019 Outside Hubei Province in China.
    Nie X; Fan L; Mu G; Tan Q; Wang M; Xie Y; Cao L; Zhou M; Zhang Z; Chen W
    J Infect Dis; 2020 Jun; 222(1):26-33. PubMed ID: 32339231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prolonged incubation period and centralized quarantine on the COVID-19 outbreak in Shijiazhuang, China: a modeling study.
    Zhu W; Zhang M; Pan J; Yao Y; Wang W
    BMC Med; 2021 Dec; 19(1):308. PubMed ID: 34872559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of Incubation Period and Serial Interval for SARS-CoV-2 in Jiangxi, China, and an Updated Meta-Analysis.
    Zhang T; Ding S; Zeng Z; Cheng H; Zhang C; Mao X; Pan H; Xia G; Che D
    J Infect Dev Ctries; 2021 Mar; 15(3):326-332. PubMed ID: 33839705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatio-temporal evolution and influencing mechanism of the COVID-19 epidemic in Shandong province, China.
    Shi J; Gao X; Xue S; Li F; Nie Q; Lv Y; Wang J; Xu T; Du G; Li G
    Sci Rep; 2021 Apr; 11(1):7811. PubMed ID: 33837241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiological characteristics and effectiveness of countermeasures to contain coronavirus disease 2019 in Ningbo City, Zhejiang Province, China.
    Lao X; Luo L; Lei Z; Fang T; Chen Y; Liu Y; Ding K; Zhang D; Wang R; Zhao Z; Rui J; Zhu Y; Xu J; Wang Y; Yang M; Yi B; Chen T
    Sci Rep; 2021 May; 11(1):9545. PubMed ID: 33953243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study of the epidemic situation on COVID-19 in Gansu Province, China - a big data analysis of the national health information platform.
    Yan X; Wang J; Yao J; Estill J; Wu S; Lu J; Liang B; Li H; Tao S; Bai H; Liu H; Chen Y;
    BMC Infect Dis; 2021 Feb; 21(1):146. PubMed ID: 33546618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the effect of age on quantiles of the incubation period distribution of COVID-19.
    Liu X; Wang L; Ma X; Wang J; Wu L
    BMC Public Health; 2021 Sep; 21(1):1762. PubMed ID: 34579681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for pre-symptomatic transmission of coronavirus disease 2019 (COVID-19) in China.
    Ren X; Li Y; Yang X; Li Z; Cui J; Zhu A; Zhao H; Yu J; Nie T; Ren M; Dong S; Cheng Y; Chen Q; Chang Z; Sun J; Wang L; Feng L; Gao GF; Feng Z; Li Z
    Influenza Other Respir Viruses; 2021 Jan; 15(1):19-26. PubMed ID: 32767657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological analysis of 18 patients with COVID-19.
    Chen G; Wu MZ; Qin CJ; Wu BB; Luo WR; Liu L; Liu JY
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12522-12526. PubMed ID: 33336772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological study on severe acute respiratory syndrome coronavirus 2 virus transmission network in northeast China.
    Feng T; Zhang Y; Sun H; Zhang H; Sun M; Wang Y; Sun C; Li K; Wang Y; Chai R; Zheng P; Chen Y; Pan P; Bi C; Yao Y; Liu S
    Medicine (Baltimore); 2021 Jul; 100(26):e26298. PubMed ID: 34190148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of incubation period and serial interval of COVID-19: analysis of 178 cases and 131 transmission chains in Hubei province, China.
    Yang L; Dai J; Zhao J; Wang Y; Deng P; Wang J
    Epidemiol Infect; 2020 Jun; 148():e117. PubMed ID: 32594928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the effectiveness of measures to control the novel coronavirus disease 2019 in Jilin Province, China.
    Zhao Q; Wang Y; Yang M; Li M; Zhao Z; Lu X; Shen B; Luan B; Zhao Y; Cao B; Yao L; Zhao B; Su Y; Chen T
    BMC Infect Dis; 2021 Mar; 21(1):245. PubMed ID: 33676420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demand for longer quarantine period among common and uncommon COVID-19 infections: a scoping review.
    Li ZY; Zhang Y; Peng LQ; Gao RR; Jing JR; Wang JL; Ren BZ; Xu JG; Wang T
    Infect Dis Poverty; 2021 Apr; 10(1):56. PubMed ID: 33902695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological characteristics of confirmed COVID-19 in Guizhou province, China.
    Li X; Wang X; Liu J; Huang G; Shi X
    Disaster Med Public Health Prep; 2020 Dec; 14(6):769-775. PubMed ID: 32367793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
    Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y
    Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of coronavirus disease 2019 in Gansu province, China.
    Yue H; Bai X; Wang J; Yu Q; Liu W; Pu J; Wang X; Hu J; Xu D; Li X; Kang N; Li L; Lu W; Feng T; Ding L; Li X; Qi X;
    Ann Palliat Med; 2020 Jul; 9(4):1404-1412. PubMed ID: 32692208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological and Clinical Characteristics of Patients With Coronavirus Disease-2019 in Shiyan City, China.
    Liu L; Lei X; Xiao X; Yang J; Li J; Ji M; Du W; Tan H; Zhu J; Li B; Jin Z; Liu W; Wu J; Liu Z
    Front Cell Infect Microbiol; 2020; 10():284. PubMed ID: 32574282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective control of SARS-CoV-2 transmission in Wanzhou, China.
    Shi Q; Hu Y; Peng B; Tang XJ; Wang W; Su K; Luo C; Wu B; Zhang F; Zhang Y; Anderson B; Zhong XN; Qiu JF; Yang CY; Huang AL
    Nat Med; 2021 Jan; 27(1):86-93. PubMed ID: 33257893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.